yervoy
(ipilimumab)E.R. Squibb & Sons, L.L.C.
Usage: YERVOY is indicated for treating unresectable or metastatic melanoma, adjuvant melanoma post-resection, advanced renal cell carcinoma, microsatellite instability-high colorectal cancer, hepatocellular carcinoma, metastatic non-small cell lung cancer, malignant pleural mesothelioma, and unresectable esophageal cancer, often in combination with nivolumab.